Novir: Funding, Investors & Team (Sep 2026)
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted partners delivering smart.
Novir has raised $3.1M across 1 funding round on record, the most recent a Seed of $3.1M announced in Aug 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Novir Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Novir Funding Rounds
Novir Founders and Leadership Team
Contact details for the Novir team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Novir Funding Compared to Other Biotechnology Startups
Novir's latest round of $3.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Novir in Biotechnology and Milwaukee
Companies Similar to Novir
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Novir Funding FAQs
What does Novir do?
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted partners delivering smart.
How much funding has Novir raised?
Novir has raised $3.1M across 1 round on record. The most recent is a Seed of $3.1M announced in Aug 2026.
When did Novir last raise funding?
Novir's most recent funding round on record is a Seed of $3.1M, announced in Aug 2026.
Who founded Novir?
FundedIQ lists Alexander Orozco (CEO and Founder) at Novir.
Where is Novir headquartered?
Novir is based in Milwaukee, United States.
How many employees does Novir have?
Novir is in the 51-100 employee band.
When was Novir founded?
Novir was founded in 2020.
How does Novir's funding compare to other Biotechnology startups?
Novir's latest round of $3.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Novir Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Novir is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.